|
Economics, Pharmaceutical
|
N03.219.390 |
|
|
Otoscopes
|
E07.230.550 |
|
|
Factor XIIa
|
D08.811.277.656.959.350.324 |
|
|
Neurofibrils
|
A11.284.430.214.190.750.640 |
|
|
Narcotics
|
D27.505.696.277.600 |
|
|
Telophase
|
G04.144.220.220.781.953 |
|
|
Fraser Syndrome
|
C16.131.384.442 |
|
|
Factor XIa
|
D08.811.277.656.959.350.320 |
|
|
Electron Transport
|
G03.295.531.403 |
|
|
Refractory Period, Electrophysiological
|
G07.265.753.770 |
|
|
Neural Conduction
|
G07.265.753 |
|
|
Paraparesis, Spastic
|
C23.888.592.643.500.500 |
|
|
Paraparesis
|
C23.888.592.643.500 |
|
|
Anencephaly
|
C10.500.680.196 |
|
|
Uterine Cervical Erosion
|
C13.351.500.852.593.112 |
|
|
Prolamins
|
D12.776.765.725.500 |
|
|
Optic Neuropathy, Ischemic
|
C10.292.700.600 |
|
|
Factor XIII
|
D12.776.811.243.505 |
|
|
Nitrites
|
D01.625.600.600 |
|
|
Nitrous Acid
|
D01.625.600 |
|
